このエントリーをはてなブックマークに追加
ID 71007
フルテキストURL
fulltext.pdf 4.68 MB
著者
Bose, Puja Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
Halder, Gourab Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
Kayet, Pratanu Division of Bioinformatics, ICMR-National Institute for Research in Bacterial Infections
Chowdhury, Goutam Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
Basak, Surajit Division of Bioinformatics, ICMR-National Institute for Research in Bacterial Infections
Roy, Deboleena Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
Imamura, Daisuke Research Center for Intestinal Health Science, Okayama University
Miyoshi, Shin-ichi Research Center for Intestinal Health Science, Okayama University
Morita, Masatomo Department of Bacteriology I, National Institute of Infectious Diseases
Ramamurthy, Thandavarayan Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
Koley, Hemanta Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
Das, Santasabuj Division of Clinical Medicine, ICMR-National Institute for Research in Bacterial Infections
Mukhopadhyay, Asish Kumar Division of Bacteriology, ICMR-National Institute for Research in Bacterial Infections
抄録
Shigella spp. is recognized by the World Health Organization as a high-priority pathogen due to its global prevalence, unique pathogenic mechanisms, and growing antimicrobial resistance (AMR). Nearly half of all Shigella strains worldwide are now multidrug-resistant (MDR), and the emergence of extensively drug-resistant (XDR) variants—resistant to ciprofloxacin, ceftriaxone, and azithromycin—has severely limited effective treatment options. The present study is based on prospective laboratory surveillance involving 323 Shigella isolates collected during 2021–2023, with pre-COVID-19 pandemic data included from a previously published study solely for historical comparison. The presence of antibiotic resistance genes (ARGs) was investigated, and whole-genome sequencing (WGS) was performed on representative isolates to assess phylogenetic relatedness with global isolates. Approximately 10% of isolates exhibited resistance to third-generation cephalosporins. While only 3% of Shigella isolates carried the blaCTX-M-15 gene from 2013 to 2019, its prevalence increased to 26% by 2022–2023. Among 38 ceftriaxone-resistant S. sonnei isolates, 33 were also resistant to azithromycin, categorizing them as XDR. These isolates showed 48% clonal similarity and high phylogenetic resemblance to the isolates reported from England. Hybrid genome assembly revealed a plasmid harboring both the blaCTX-M-15 and mphA ARGs. Conjugation experiments and plasmid profiling confirmed the plasmid’s transferability. We report a rising trend in third-generation cephalosporin resistance among Shigella spp., primarily driven by the spread of extended-spectrum β-lactamase-producing S. flexneri and the emergence of XDR S. sonnei. These findings underscore the urgent need for strengthened national AMR containment strategies and enhanced international surveillance of cephalosporin-resistant Shigella to mitigate this growing public health threat.
キーワード
dysentery
AMR
XDR
Shigella spp.
CTX-M
plasmid
transconjugants
PFGE
WGS
発行日
2026-07-24
出版物タイトル
Microbiology Spectrum
出版者
American Society for Microbiology
開始ページ
e02824-25
ISSN
2165-0497
資料タイプ
学術雑誌論文
言語
英語
OAI-PMH Set
岡山大学
著作権者
© 2026 Bose et al.
論文のバージョン
publisher
PubMed ID
DOI
Web of Science KeyUT
関連URL
isVersionOf https://doi.org/10.1128/spectrum.02824-25
ライセンス
https://creativecommons.org/licenses/by/4.0/
Citation
Bose P, Halder G, Kayet P, Chowdhury G, Basak S, Roy D, Imamura D, Miyoshi S, Morita M, Ramamurthy T, Koley H, Das S, Mukhopadhyay AK.0.Escalation of CTX-M-producing extensively drug-resistant Shigella spp. in Kolkata, India, following the COVID-19 pandemic. Microbiol Spectr0:e02824-25.https://doi.org/10.1128/spectrum.02824-25
助成情報
( Indian Council of Medical Research )
( National Institute of Infectious Diseases )
( Japan Initiative for Global Research Network on Infectious Diseases )
( 文部科学省 / Ministry of Education )
21wm0125004: インド国コルカタ市を拠点とする感染性下痢症のリザーバー及び伝播と拡散に関する研究 ( 国立研究開発法人日本医療研究開発機構 / Japan Agency for Medical Research and Development )
23wm0225021: 新興Escherichia属病原細菌とHybrid型病原性大腸菌のサーベイランスと出現様式の解明 ( 国立研究開発法人日本医療研究開発機構 / Japan Agency for Medical Research and Development )